184 related articles for article (PubMed ID: 6381610)
1. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
Hayden FG; Gwaltney JM
J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
[TBL] [Abstract][Full Text] [Related]
2. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
Hayden FG; Gwaltney JM
J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
[TBL] [Abstract][Full Text] [Related]
3. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
Farr BM; Gwaltney JM; Adams KF; Hayden FG
Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
[TBL] [Abstract][Full Text] [Related]
4. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
Hayden FG; Kaiser DL; Albrecht JK
Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
Samo TC; Greenberg SB; Couch RB; Quarles J; Johnson PE; Hook S; Harmon MW
J Infect Dis; 1983 Sep; 148(3):535-42. PubMed ID: 6619578
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
[TBL] [Abstract][Full Text] [Related]
7. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
[TBL] [Abstract][Full Text] [Related]
8. Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose.
Samo TC; Greenberg SB; Palmer JM; Couch RB; Harmon MW; Johnson PE
J Infect Dis; 1984 Aug; 150(2):181-8. PubMed ID: 6381611
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
[TBL] [Abstract][Full Text] [Related]
11. An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2.
Phillpotts RJ; Scott GM; Higgins PG; Wallace J; Tyrrell DA; Gauci CL
Antiviral Res; 1983 Aug; 3(2):121-36. PubMed ID: 6312877
[TBL] [Abstract][Full Text] [Related]
12. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.
Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM
J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684
[TBL] [Abstract][Full Text] [Related]
13. Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2.
Hayden FG; Mills SE; Johns ME
J Infect Dis; 1983 Nov; 148(5):914-21. PubMed ID: 6355321
[TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental coronavirus colds with intranasal alpha-2b interferon.
Turner RB; Felton A; Kosak K; Kelsey DK; Meschievitz CK
J Infect Dis; 1986 Sep; 154(3):443-7. PubMed ID: 3016111
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting.
Douglas RM; Moore BW; Miles HB; Davies LM; Graham NM; Ryan P; Worswick DA; Albrecht JK
N Engl J Med; 1986 Jan; 314(2):65-70. PubMed ID: 3001518
[TBL] [Abstract][Full Text] [Related]
16. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
Hayden FG; Turner RB; Gwaltney JM; Chi-Burris K; Gersten M; Hsyu P; Patick AK; Smith GJ; Zalman LS
Antimicrob Agents Chemother; 2003 Dec; 47(12):3907-16. PubMed ID: 14638501
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha 2 in natural respiratory viral infections.
Hayden FG; Gwaltney JM; Johns ME
Antiviral Res; 1985 Apr; 5(2):111-6. PubMed ID: 4015079
[TBL] [Abstract][Full Text] [Related]
18. Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.
Herzog C; Berger R; Fernex M; Friesecke K; Havas L; Just M; Dubach UC
Antiviral Res; 1986 May; 6(3):171-6. PubMed ID: 3524441
[TBL] [Abstract][Full Text] [Related]
19. Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers.
Higgins PG; Al-Nakib W; Willman J; Tyrrell DA
J Interferon Res; 1986 Apr; 6(2):153-9. PubMed ID: 3014018
[TBL] [Abstract][Full Text] [Related]
20. Trials of interferon in respiratory infections in man.
Greenberg SB; Harmon MW; Tyrrell DA; Scott GM
Tex Rep Biol Med; 1981-1982; 41():549-54. PubMed ID: 6763365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
